IRCT20100520003982N1已完成3 期
Effect of oral propranolol in retinopathy of prematurity
Yazd University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 182 days 至 224 days（—）
- 性别
- All
入选标准
- •Preterm infants less than 1500 gr
- •Preterm infants with gestational age greater than 26 weeks and less than 32 weeks
- •Preterm infants with retinopathy grade I and II ROP
- •Preterm infants admitted to NICU.
排除标准
- •Congenital malformation
- •cardiovascular problems except Patent Ductus Arteriosus (PAD)
- •active sepsis
- •Congenital infections (TORCH)
- •Intraventricular hemorrhage (IVH) Grade II and III
研究者
相似试验
已完成
不适用
Prevention of blindness in preterm infantsCTRI/2013/11/004131ONE52
进行中（未招募）
不适用
Safety and efficacy of propranolol eye drops in neonates with retinopathy of prematurity: a pilot study (DROP-ROP).The medical condition to be investigated is Retinopathy of Prematurity (ROP)EUCTR2013-002062-39-ITAzienda Ospedaliero-Universitaria Meyer
已完成
不适用
Clinical study of oral propranolol treatment for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000004453Gifu University Graduate School of Medicine50
已完成
2 期
Intravitreal propranolol in patient with persistent clinically significant diabetic macular edemaIRCT20231027059872N1Tabriz University of Medical Sciences10
招募中
1 期
Evaluating the effect of oral Propranolol in preventing the progression of retinopathy of prematurityretinopathy of prematurity.Retinopathy of prematurity, unspecified, bilateralH35.103IRCT20230717058817N1Ardabil University of Medical Sciences66